文献速递白血病

E3泛素连接酶HOIP的基因缺失与药理抑制损害髓系白血病的传播

Genetic deletion and pharmacologic inhibition of E3 ubiquitin ligase HOIP impairs the propagation of myeloid leukemia.
PubMed 文献 · Leukemia · 2022-11-09

该研究通过条件性敲除Hoip及小分子抑制剂,在多种小鼠髓系白血病模型中证实Hoip缺失可延长生存并减轻白血病负荷,且HOIP缺失诱导白血病干细胞凋亡而不影响造血干细胞;噻唑啉(thiolutin)抑制HOIP催化活性可改善受体小鼠生存并抑制患者来源异种移植模型中的白血病传播。

要点

  • 条件性敲除Hoip可显著延长小鼠髓系白血病模型生存并明显减轻白血病负荷。
  • HOIP缺失损害造血干细胞和白血病干细胞的静息维持,但仅在体内诱导白血病干细胞凋亡。
  • 抑制HOIP催化活性的噻唑啉可改善小鼠髓系白血病受体生存并抑制PDX模型传播。

核心结论

  • 抑制LUBAC活性可能是髓系白血病的有效治疗靶点。

研究设计与样本

  • 研究采用Hoip条件性敲除和小分子HOIP化学抑制剂,在成年造血及髓系白血病模型中进行。

主要发现

  • 条件性敲除Hoip导致小鼠髓系白血病模型生存显著延长、白血病负荷明显减轻。
  • 竞争性移植实验显示,条件性敲除Hoip后受体小鼠骨髓中供体来源细胞减少相对温和。
  • Hoip缺陷的造血干细胞和白血病干细胞均损害静息维持,但条件性敲除Hoip在体内诱导白血病干细胞凋亡而非造血干细胞。
  • 结构功能分析显示LUBAC连接酶活性及LUBAC亚基间相互作用对白血病传播至关重要。
  • HOIP在白血病中独立于核因子κB通路调控氧化磷酸化通路,而在正常造血细胞中不如此。

临床怎么用

  • 原文结论指出抑制LUBAC活性可能是髓系白血病的有效治疗靶点。
  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We investigated the role of Hoip, a catalytic subunit of linear ubiquitin chain assembly complex (LUBAC), in adult hematopoiesis and myeloid leukemia by using both conditional deletion of Hoip and small-molecule chemical inhibitors of Hoip. Conditional deletion of Hoip led to significantly longer survival and marked depletion of leukemia burden in murine myeloid leukemia models. Nevertheless, a competitive transplantation assay showed the reduction of donor-derived cells in the bone marrow of recipient mice was relatively mild after conditional deletion of Hoip. Although both Hoip-deficient hematopoietic stem cells (HSCs) and leukemia stem cells (LSCs) impaired the maintenance of quiescence, conditional deletion of Hoipinduced apoptosis in LSCs but not HSCs in vivo. Structure-function analysis revealed that LUBAC ligase activity and the interaction of LUBAC subunits were critical for the propagation of leukemia. Hoip regulated oxidative phosphorylation pathway independently of nuclear factor kappa B pathway in leukemia, but not in normal hematopoietic cells. Finally, the administration of thiolutin, which inhibits the catalytic activity of Hoip, improved the survival of recipients in murine myeloid leukemia and suppressed propagation in the patient-derived xenograft model of myeloid leukemia. Collectively, these data indicate that inhibition of LUBAC activity may be a valid therapeutic target for myeloid leukemia.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Jimbo K, Hattori A, Koide S, et al. Genetic deletion and pharmacologic inhibition of E3 ubiquitin ligase HOIP impairs the propagation of myeloid leukemia. Leukemia. 2022. PMID: 36352193. doi:10.1038/s41375-022-01750-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。